LOADING
Comparing Coca-Cola Company (KO) and Pfizer Inc (PFE) across the Consumer Staples and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | KO | PFE |
|---|---|---|
| Price | $81.34 | $24.09 |
| Change Today | +1.28% | -2.57% |
| Market Cap | $345.5B | $142.9B |
| P/E Ratio | 25.0 | 19.1 |
| Forward P/E | 24.4 | 8.5 |
| PEG Ratio | 4.07 | 3.77 |
| EPS | $3.21 | $1.31 |
| Revenue Growth (YoY) | 12.1% | 5.4% |
| Profit Margin | 27.8% | 11.8% |
| Return on Equity | 43.4% | 8.3% |
| Dividend Yield | 2.59% | 6.82% |
| Beta | 0.35 | 0.29 |
| 52-Week High | $83.50 | $28.28 |
| 52-Week Low | $64.04 | $21.97 |
| Volume | 461K | 1.8M |
Coca-Cola Company is the larger company by market capitalization. Pfizer Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Pfizer Inc offers a higher dividend yield for income investors. Coca-Cola Company has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.